Prognostic factors in oropharyngeal cancer – analysis of 627 cases receiving definitive radiotherapy

References

• Ferlay, J, Bray, F, Pisani, P, Parkin, DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press; 2004.
   Google Scholar
• National Cancer Registry Programme. Two year report of population based cancer registries 1997-1998. Bangalore: Indian Council of Medical Research; 2002.
   Google Scholar
• Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709–20
   PubMed Web of Science ®Google Scholar
• Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 3187–92
   PubMed Web of Science ®Google Scholar
• Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, et al. Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada. Oral Oncol 2008; 44: 242–50
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261–9
   PubMed Web of Science ®Google Scholar
• Bataini JP, Asselain B, Jaulerry C, Brunin F, Bernier J, Pontvert D, et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors. Radiother Oncol 1989; 14: 265–77
   PubMed Web of Science ®Google Scholar
• Jaulerry C, Rodriguez J, Brunin F, Mosseri V, Pontvert D, Brugere J, et al. Results of radiation therapy in carcinoma of the base of the tongue. The Curie Institute experience with about 166 cases. Cancer 1991; 67: 1532–8
   PubMed Web of Science ®Google Scholar
• Regueiro CA, Aragon G, Millan I, Valcarcel FJ, de la Torre A, Magallon R. Prognostic factors for local control, regional control and survival in oropharyngeal squamous cell carcinoma. Eur J Cancer 1994; 30A: 2060–7
   PubMedGoogle Scholar
• Perez CA, Patel MM, Chao KS, Simpson JR, Sessions D, Spector GJ, et al. Carcinoma of the tonsillar fossa: Prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 1998; 42: 1077–84
   PubMed Web of Science ®Google Scholar
• Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oropharynx–an analysis of treatment results in 289 consecutive patients. Acta Oncol 2000; 39: 985–94
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Malyapa RS, Werning JW, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 2006; 29: 290–7
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Werning JW, Villaret DB. Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol 2006; 29: 32–9
   PubMedGoogle Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–6
   PubMed Web of Science ®Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–14
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69–76
   PubMed Web of Science ®Google Scholar
• Cooper JS, Farnan NC, Asbell SO, Rotman M, Marcial V, Fu KK, et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 1996; 77: 1905–11
   PubMedGoogle Scholar
• Jeremic B, Milicic B. Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol 2008; 31: 213–8
   PubMedGoogle Scholar
• Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 2006; 95: 1432–8
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467–75
   PubMed Web of Science ®Google Scholar
• Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer. 2007; 121: 1813–20
   PubMed Web of Science ®Google Scholar
• Lee WR, Mendenhall WM, Parsons JT, Million RR, Cassisi NJ, Stringer SP. Carcinoma of the tonsillar region: A multivariate analysis of 243 patients treated with radical radiotherapy. Head Neck 1993; 15: 283–8
   PubMed Web of Science ®Google Scholar
• Mak-Kregar S, Baris G, Lebesque JV, Balm AJ, Hart AA, Hilgers FJ. Radiotherapy of tonsillar and base of the tongue carcinoma. Prediction of local control. Eur J Cancer B Oral Oncol 1993; 29B: 119–25
   PubMedGoogle Scholar
• Hannisdal K, Boysen M, Evensen JF. Different prognostic indices in 310 patients with tonsillar carcinomas. Head Neck 2003; 25: 123–31
   PubMed Web of Science ®Google Scholar
• Johansen LV, Overgaard J, Overgaard M, Birkler N, Fisker A. Squamous cell carcinoma of the oropharynx: An analysis of 213 consecutive patients scheduled for primary radiotherapy. Laryngoscope 1990; 100: 985–90
   PubMed Web of Science ®Google Scholar
• van Putten WL, van der Sangen MJ, Hoekstra CJ, Levendag PC. Dose, fractionation and overall treatment time in radiation therapy–the effects on local control for cancer of the larynx. Radiother Oncol 1994; 30: 97–108
   PubMed Web of Science ®Google Scholar
• Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, et al. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995; 33: 549–62
   PubMed Web of Science ®Google Scholar
• Hoffstetter S, Marchal C, Peiffert D, Luporsi E, Lapeyre M, Pernot M, et al. Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy. Radiother Oncol 1997; 45: 141–8
   PubMedGoogle Scholar
• Agarwal, JP, Budrukkar, A, Laskar, SG. Unplanned interruptions: Unresolved issues: in regard to Bese et al. (Int J Radiat Oncol Biol Phys 2007;68:654–61). Int J Radiat Oncol Biol Phys 2007;69:1335–6, Author reply 1336
   PubMedGoogle Scholar
• Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet 2006; 368: 843–54
   PubMed Web of Science ®Google Scholar
• Overgaard J, Mohanti B, Bhasker S, Begum N, Ali R, Agarwal J, et al. Accelerated versus conventional fractionated radiotherapy in squamous cell carcinoma of the head and neck (SCCHN). A randomized international multicenter trial with 908 patients conducted by the IAEA-ACC study group. Int J Radiat Oncol Biol Phys 2006; 66: S13
   Google Scholar
• Ghoshal S, Goda JS, Mallick I, Kehwar TS, Sharma SC. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India. Clin Oncol (R Coll Radiol) 2008; 20: 212–20
   PubMedGoogle Scholar
• Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949–55
   PubMed Web of Science ®Google Scholar